Scientists developed and tested new artificial intelligence (AI) tools tailored to digital pathology--a rapidly growing field that uses high-resolution digital images created from tissue samples to ...

Roche has agreed to acquire PathAI, a Boston-based digital pathology firm, for up to $1.05 billion. Roche plans to pay $750 million upfront and up to $300 million in additional milestone payments, ...

Scientists from Dana-Farber Cancer Institute and Weill Cornell Medicine have developed and tested new artificial intelligence tools tailored to digital pathology—a relatively new field that uses ...

PathAI's best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiency Combining ...

In healthcare, pathology is like detective work. Pathologists meticulously examine tissues and cells to uncover the underlying causes of patients' health problems. With the global market for pathology ...

The results of research by a University of Warwick-led team warn that popular deep learning systems trained for cancer pathology may be falling short on predictive accuracy because they are missing ...

Leica Biosystems and Indica Labs have announced a strategic collaboration with Lunit (KRX:328130.KQ), a provider of AI solutions for cancer diagnostics and therapeutics, to develop AI-powered image ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses and cheaper testing. But new research from the ...

Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute in Boston have developed and tested new artificial intelligence (AI) tools tailored to digital pathology—a rapidly growing ...